3.64BMarket Cap-5362P/E (TTM)
44.575High43.710Low450.42KVolume44.160Open43.850Pre Close19.92MTurnover0.62%Turnover RatioLossP/E (Static)82.34MShares54.98052wk High13.23P/B3.19BFloat Cap31.52052wk Low--Dividend TTM72.17MShs Float179.647Historical High--Div YieldTTM1.97%Amplitude31.520Historical Low44.232Avg Price1Lot Size
Ultragenyx Pharmaceutical Stock Forum
🎯 Ph 3 readouts in Q2 2024...
$CG Oncology(CGON.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$United Therapeutics(UTHR.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3
$Insmed(INSM.US)$ Phase 3
$GlycoMimetics(GLYC.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$Lyra Therapeutics(LYRA.US)$ Phase 3
$Citius Pharmaceuticals(CTXR.US)$ Phase 3
$Jaguar Health(JAGX.US)$ Phas...
Biotech Stock Catalyst Watchlist
$Intra-Cellular Therapies(ITCI.US)$ Phase 3
$CG Oncology(CGON.US)$ Phase 3
$Hutchmed (China)(HCM.US)$ Phase 3
$Viracta Therapeutics(VIRX.US)$ Phase 3
$GlycoMimetics(GLYC.US)$ Phase 3
$Annexon(ANNX.US)$ Phase 3
$Lipocine(LPCN.US)$ Phase 3
$FibroGen(FGEN.US)$ Phase 3
$UroGen Pharma Ltd(URGN.US)$ Phase 3
$Lyra Therapeutics(LYRA.US)$ Phase 3
$Citius Pharmaceuticals(CTXR.US)$ Phase 3
$Marinus Pharmaceuticals(MRNS.US)$ Phase 3
$BioCardia(BCDA.US)$ Phase 3...
ColumnsToday's pre-market stock movers: NFLX, IBM, LMT, SI and more
In reaction to earnings/guidance:
• $Silvergate Capital(SI.US)$ +10.7% (Silvergate (ticker: SI) notched net income of $38.6 million in the June quarter, delivering earnings per share (EPS) of $1.13.)
• $AxoGen(AXGN.US)$ +3.3% (guides Q2 revs above consensus; also makes changes to its commercial organization),
• $Novartis AG(NVS.US)$ + 3% (The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from...
ColumnsTop upgrades and downgrades on 3/16
• $ACADIA Pharmaceuticals(ACAD.US)$: Canaccord Genuity Upgrades to Buy from Hold - PT $31 (from $30)
• $Host Hotels & Resorts(HST.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $21
• $Magna International(MGA.US)$: Raymond James Upgrades to Market Perform from Underperform - PT $68
• $Micron Technology(MU.US)$: Bernstein Upgrades to Outperform from Market Perform - PT $94 (from $58)
• $Ultragenyx Pharmaceutical(RARE.US)$: Credit Sui...
Trader tip
Much of what we attribute to chance is just stubborn persistence.
Knowing what to do is very different from doing what you have to do.
Growth is what keeps life interesting, and it comes from doing hard stuff.
$Fate Therapeutics(FATE.US)$ $Ultragenyx Pharmaceutical(RARE.US)$ $Macy's(M.US)$ $Palantir(PLTR.US)$ $GameStop(GME.US)$ $Nano Dimension(NNDM.US)$ $Denali Therapeutics(DNLI.US)$ $Alarm.com(ALRM.US)$
No comment yet